Research Leaders / KOL Map

Eosinophilic Esophagitis: Research Leaders and Landscape

The most active researchers, institutions, and subtopics in Eosinophilic Esophagitis, from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 194 recent PubMed papers (2021-2026) matching "eosinophilic esophagitis dupilumab treatment". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1Chehade MirnaMount Sinai Center for Eosinophilic Disorders13
2Maloney JenniferRegeneron Pharmaceuticals Inc8
3Radwan AmrRegeneron Pharmaceuticals Inc7
4Savarino Edoardo VincenzoUniversity of Padua7
5Visaggi PierfrancescoUniversity of Pisa6
6Di Sabatino AntonioUniversity of Pavia6
7Rossi Carlo MariaUniversity of Pavia6
8Shabbir ArsalanRegeneron Pharmaceuticals Inc.6
9Radin AllenRegeneron Pharmaceuticals Inc.5
10Leung JohnBoston Specialists5
11Oliva SalvatoreSapienza University of Rome5
12Glotfelty LilaSanofi5
13Hirano IkuoNorthwestern University Feinberg School of Medicine5
14Laws ElizabethSanofi5
15Menard-Katcher CaliesChildren's Hospital Colorado4
16Louisias MargeeSanofi4
17Ghisa MatteoUniversity of Padua4
18Mennini MaurizioSapienza University of Rome4

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

University of North Carolina School of Medicine (21), Sanofi (18), Children's Hospital of Philadelphia (14), Mount Sinai Center for Eosinophilic Disorders (10), Cincinnati Children's Hospital Medical Center (10), University of Pavia (8), Children's Hospital Colorado (7), Regeneron Pharmaceuticals Inc. (7), University of Padua (7), University of Pisa (7)

Active subtopics

Eosinophilic Esophagitis (102), Antibodies, Monoclonal, Humanized (79), Eosinophilia (39), Treatment Outcome (38), Gastritis (37), Child (35), Enteritis (35), Proton Pump Inhibitors (30), Eosinophils (19)

Top journals

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (9), The American journal of gastroenterology (7), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (7), Journal of pediatric gastroenterology and nutrition (6), The journal of allergy and clinical immunology. In practice (5), The Journal of allergy and clinical immunology (5)

Representative recent papers

Efficacy and Safety of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis. (2026) · PMID 42455743

Dupilumab Improves Endoscopic Features in Children Aged 1-11 Years With Eosinophilic Esophagitis: EoE KIDS Study Results. (2026) · PMID 42430733

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis. (2026) · PMID 42361381

Dupilumab Is Safe and Efficacious for Treatment of Eosinophilic Esophagitis and Atopic Dermatitis in Pediatric Liver Transplant Re (2026) · PMID 42351377

Safety of dupilumab use during pregnancy: A composite evaluation of pregnancy outcomes. (2026) · PMID 42343498

Want the full cited brief?

A full Eosinophilic Esophagitis brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us